Level C· Early human research exploring benefitsProspective StudyPubMed

Precocious subcutaneous abdominal stem cell development to adipocytes in normal-weight women with polycystic ovary syndrome.

Fisch SC., Nikou AF., Wright EA., Phan JD., Leung KL., Grogan TR.

Prospective Study on Systemic / IV, published in Fertil Steril (2018) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Fertil Steril (2018)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
30503136
PMCID
PMC6287278
DOI
10.1016/j.fertnstert.2018.08.042
Citations
31

Abstract (original English)

Objective To examine whether abnormal subcutaneous (SC) abdominal adipose stem cell (ASC) development to adipocytes in polycystic ovary syndrome (PCOS) correlates with hyperandrogenism. Design Prospective cohort study. Setting Academic medical center. Patient(s) Eight normal-weight women with PCOS and eight normoandrogenic ovulatory (control) women matched for age and body mass index. Intervention(s) Circulating hormone and metabolic measurements, intravenous glucose tolerance testing, total body dual-energy X-ray absorptiometry, and SC abdominal fat biopsy. Main outcome measure(s) In vitro ASC commitment to preadipocytes (ZFP423 protein expression, day 0.5), preadipocyte differentiation to adipocytes (PPARγ gene expression, day 3) and adipocyte lipid content (Oil-Red-O fluorescence, day 12) comparisons correlated with clinical outcomes. Result(s) In women with PCOS, SC abdominal ASCs compared with those of control women showed exaggerated commitment to preadipocytes and had greater lipid content in newly formed adipocytes after in vitro maturation. In all women combined, ZFP423 protein expression negatively correlated with fasting plasma glucose levels whereas the lipid content of newly formed adipocytes positively correlated with both PPARγ gene expression and serum free testosterone levels. Conclusion(s) In normal-weight women with PCOS compared with the control group, exagg

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Abdominal FatAbsorptiometry, PhotonAdipocytesAdipogenesisAdolescentAdultAdult Stem CellsBody Mass IndexCase-Control StudiesCell Differentiation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research